Step 1 topics → Immunology → Vaccine Types and Contraindications

Vaccine Types and Contraindications

USMLE Step 1 trap: Restricts live vaccine contraindication to T cell deficiency, missing other immunocompromised states and pregnancy. Live attenuated vaccines are contraindicated in all significantly immunocompromised patients (T cell deficiency, SCID, high-dose steroids, active chemotherapy, HIV with CD4 <200) and in pregnant women.

Vaccines are one of the highest-yield immunology topics on USMLE Step 1, and the exam tests them from multiple angles: classification and examples, clinical contraindications, immunological mechanisms, and population-level effects. You need to know not just which vaccine is which type, but why that type behaves the way it does immunologically — because the exam will give you a scenario and ask you to reason through it. A question might describe an HIV patient asking about MMR, or a public health official calculating how much of a population needs to be vaccinated to stop measles — and expect you to apply underlying principles, not just recite a list.

The tricky part is that students tend to memorize surface-level rules without understanding the logic underneath. For example, many students know 'live vaccines are contraindicated in immunocompromised patients' but mentally restrict that to T cell deficiencies — missing patients on high-dose steroids, active chemotherapy, or HIV with CD4 below 200. Similarly, students often treat killed and live vaccines as interchangeable immunologically, when the entire reason boosters and adjuvants exist is that they are not. The exam loves to exploit these gaps.

USMLE Step 1 also tests adjuvant function and herd immunity thresholds at a mechanistic level. Adjuvants are frequently misunderstood as directly activating lymphocytes — they don't. And herd immunity thresholds are not a fixed percentage; they depend on R0, and measles (R0 ~15) is the classic high-yield example of why this matters. Build the logic, not just the list.

From real student decks
84%have cards covering this topic
84%have mature cards
2median lapses in 14 days

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Live attenuated vaccines are contraindicated only in patients with T cell deficiencies.
Right: Live attenuated vaccines are contraindicated in all significantly immunocompromised patients (T cell deficiency, SCID, high-dose steroids, active chemotherapy, HIV with CD4 <200) and in pregnant women.
Restricting live vaccine contraindications to T cell deficiencies misses the broader principle: any significant impairment of cell-mediated immunity can allow a live attenuated organism to replicate unchecked and cause disease. This includes patients on high-dose corticosteroids (≥20 mg prednisone for ≥2 weeks), those receiving active chemotherapy, and HIV-positive patients with CD4 counts below 200. Pregnancy is also a contraindication because of theoretical fetal risk. The rule is: if the immune system cannot contain a replicating attenuated pathogen, do not give it.
Common mistake
Wrong: Killed/inactivated vaccines produce the same immune response as live attenuated vaccines.
Right: Live attenuated vaccines produce stronger, longer-lasting immunity (often lifelong with one dose) because they replicate and mimic natural infection, while killed vaccines require boosters and often adjuvants to achieve adequate responses.
Live attenuated vaccines replicate inside the host, mimicking natural infection — this means prolonged antigen presentation, robust T cell activation, and strong germinal center reactions that produce long-lived plasma cells and memory. Killed or inactivated vaccines present antigen once without replication, which generates a weaker, shorter-lived response; this is why they require booster doses and often adjuvants. Equating the two ignores the fundamental reason these strategies were developed differently.
Common mistake
Wrong: Adjuvants directly stimulate antigen-specific B and T cells.
Right: Adjuvants (e.g., alum, AS04) activate innate immune cells via pattern recognition receptors, providing the danger signal and co-stimulation needed to amplify adaptive responses to the co-administered antigen.
Adjuvants do not directly activate B or T cells — they have no antigen specificity. Instead, adjuvants like alum or AS04 activate innate immune cells (dendritic cells, macrophages) by triggering pattern recognition receptors such as TLRs, mimicking the 'danger signal' that normally accompanies infection. This innate activation upregulates co-stimulatory molecules (B7/CD80/CD86) and cytokines that are required for a full adaptive immune response to the co-administered antigen. Without this step, subunit antigens alone are often poorly immunogenic.
Common mistake
Wrong: Herd immunity requires the same vaccination coverage percentage for all diseases.
Right: The herd immunity threshold is determined by R0 (basic reproduction number): threshold = 1 − 1/R0; measles (R0 ~15) requires ~95% coverage, while polio (R0 ~5) requires ~80%.
Herd immunity is not a single fixed percentage — it is mathematically tied to how contagious a disease is. The threshold is calculated as 1 − 1/R0, where R0 is the average number of secondary cases one infection generates in a fully susceptible population. Measles has an R0 of approximately 15, giving a threshold of about 93–95%; polio's lower R0 of ~5 gives a threshold of ~80%. The exam uses measles as the canonical example because its very high R0 means even small drops in vaccination coverage can trigger outbreaks — which is exactly the clinical reasoning they want you to apply.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a vaccine name or description, identify its type (live attenuated, inactivated/killed, subunit, toxoid, or mRNA) and recognize high-yield examples of each category such as MMR, varicella, IPV, hepatitis B, tetanus toxoid, and COVID-19 mRNA vaccines.
  2. Given a patient with a specific immunocompromised state or pregnancy, determine whether a live attenuated vaccine is contraindicated — including states beyond T cell deficiency such as high-dose corticosteroids, active chemotherapy, SCID, and HIV with CD4 below 200.
  3. Given a disease's R0, calculate or estimate the herd immunity threshold using the formula 1 − 1/R0, and explain why highly contagious diseases like measles require near-universal vaccination coverage to interrupt transmission.
  4. Explain why subunit and inactivated vaccines require adjuvants to generate adequate immune responses, by describing how adjuvants activate innate immune cells via pattern recognition receptors to provide the co-stimulatory danger signal — not by directly stimulating antigen-specific lymphocytes.

Can you avoid these mistakes?

A 34-year-old woman is 10 weeks pregnant and has no documentation of prior varicella vaccination or infection. Her OB asks whether she can receive the varicella vaccine now. What is your answer and what is the underlying reason?
A public health model estimates that a newly identified respiratory virus has an R0 of 10. Using the herd immunity threshold formula, what percentage of the population must be immune to halt transmission? How does this compare to a disease with R0 of 2?
A patient with HIV and a CD4 count of 350 cells/µL asks about getting the MMR vaccine before traveling internationally. A classmate says MMR is safe because the patient's CD4 is above 200 — is this reasoning correct, and why or why not?
A pharmaceutical company develops a new subunit vaccine using a single purified protein from a bacterial pathogen. Early trials show weak antibody responses. A consultant recommends adding alum to the formulation. Explain mechanistically why alum would improve the vaccine's immunogenicity — what cell types does it act on and through what pathway?

Related topics

B Cell Activation, Class Switching, Somatic Hypermutation Thymus and T Cell Maturation Spleen Architecture and Function Lymph Node and MALT Architecture Innate Immune Cells Overview

See how your Anki deck covers this topic.

Upload your deck for a free audit →